JP6530392B2 - 相乗効果を有し組織修復を行う微粒子を備えた真皮基質とその製造方法 - Google Patents

相乗効果を有し組織修復を行う微粒子を備えた真皮基質とその製造方法 Download PDF

Info

Publication number
JP6530392B2
JP6530392B2 JP2016529742A JP2016529742A JP6530392B2 JP 6530392 B2 JP6530392 B2 JP 6530392B2 JP 2016529742 A JP2016529742 A JP 2016529742A JP 2016529742 A JP2016529742 A JP 2016529742A JP 6530392 B2 JP6530392 B2 JP 6530392B2
Authority
JP
Japan
Prior art keywords
mixture
dermal
producing
collagen
resveratrol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2016529742A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016525410A5 (enExample
JP2016525410A (ja
Inventor
オズゲン オゼル，ケブセル
オズゲン オゼル，ケブセル
ホーマン ゴクセ，エブレン
ホーマン ゴクセ，エブレン
エログル，イペク
トゥンカイ タンリべルディ，サキネ
トゥンカイ タンリべルディ，サキネ
Original Assignee
デルミス ファーマ サグリク ヴェ コズメティク ウルンレリ サナイ ヴェ ティカレット アノニム シルケティ
デルミス ファーマ サグリク ヴェ コズメティク ウルンレリ サナイ ヴェ ティカレット アノニム シルケティ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by デルミス ファーマ サグリク ヴェ コズメティク ウルンレリ サナイ ヴェ ティカレット アノニム シルケティ, デルミス ファーマ サグリク ヴェ コズメティク ウルンレリ サナイ ヴェ ティカレット アノニム シルケティ filed Critical デルミス ファーマ サグリク ヴェ コズメティク ウルンレリ サナイ ヴェ ティカレット アノニム シルケティ
Publication of JP2016525410A publication Critical patent/JP2016525410A/ja
Publication of JP2016525410A5 publication Critical patent/JP2016525410A5/ja
Application granted granted Critical
Publication of JP6530392B2 publication Critical patent/JP6530392B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/26—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/60—Materials for use in artificial skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/428—Vitamins, e.g. tocopherol, riboflavin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/62—Encapsulated active agents, e.g. emulsified droplets
    • A61L2300/622—Microcapsules

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polymers & Plastics (AREA)
  • Cosmetics (AREA)
JP2016529742A 2013-07-25 2014-07-07 相乗効果を有し組織修復を行う微粒子を備えた真皮基質とその製造方法 Expired - Fee Related JP6530392B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
TR2013/09048A TR201309048A2 (tr) 2013-07-25 2013-07-25 Doku onarımı sağlayan mikropartikül içeren sinerjik etkili dermal matriks ve üretim yöntemi.
TR2013/09048 2013-07-25
PCT/TR2014/000251 WO2015012775A1 (en) 2013-07-25 2014-07-07 A dermal matrix and production method thereof having synergistic effects comprising microparticles which provides tissue repair

Publications (3)

Publication Number Publication Date
JP2016525410A JP2016525410A (ja) 2016-08-25
JP2016525410A5 JP2016525410A5 (enExample) 2019-03-22
JP6530392B2 true JP6530392B2 (ja) 2019-06-12

Family

ID=51619260

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016529742A Expired - Fee Related JP6530392B2 (ja) 2013-07-25 2014-07-07 相乗効果を有し組織修復を行う微粒子を備えた真皮基質とその製造方法

Country Status (20)

Country Link
US (1) US9517215B2 (enExample)
EP (1) EP3024505B1 (enExample)
JP (1) JP6530392B2 (enExample)
CN (1) CN105492033B (enExample)
AU (1) AU2014293717B2 (enExample)
BR (1) BR112016001573B1 (enExample)
CA (1) CA2919422C (enExample)
DK (1) DK3024505T3 (enExample)
ES (1) ES2707698T3 (enExample)
HR (1) HRP20190132T1 (enExample)
HU (1) HUE041810T2 (enExample)
LT (1) LT3024505T (enExample)
PL (1) PL3024505T3 (enExample)
PT (1) PT3024505T (enExample)
RS (1) RS58258B1 (enExample)
RU (1) RU2673665C2 (enExample)
SI (1) SI3024505T1 (enExample)
TR (1) TR201309048A2 (enExample)
WO (1) WO2015012775A1 (enExample)
ZA (1) ZA201600594B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10802190B2 (en) 2015-12-17 2020-10-13 Covestro Llc Systems, devices, and methods for curved holographic optical elements
WO2018070956A2 (en) * 2016-08-11 2018-04-19 Doku Biyoteknoloji Limited Sirketi Wound and burn material with herbal agent
CN115737887A (zh) * 2022-11-07 2023-03-07 河北大学 一种皮肤创面敷料及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100271732B1 (ko) * 1998-08-12 2000-11-15 활 서 진피재생 유도용 다공성 교원질이중구조 창상보호막
JP2003325652A (ja) * 2002-05-16 2003-11-18 Gunze Ltd 細胞組込型培養皮膚
CN1232233C (zh) * 2003-09-02 2005-12-21 中国人民解放军第四军医大学口腔医学院 一种组织工程真皮的制备方法
CN101448474A (zh) * 2006-04-12 2009-06-03 麻省理工学院 抑制粘连的组合物和方法
KR101064518B1 (ko) * 2007-09-21 2011-09-19 주식회사 운화 저장근을 가지는 초본식물의 형성층 유래 식물줄기세포주 및 이의 분리방법
CA2613026A1 (en) * 2008-01-15 2009-07-15 Gerard Voon Added new stem cells processes/methods/techniques
US20100297040A1 (en) * 2009-05-20 2010-11-25 Candace Rose Keefe Cellular age advantage; nutrient reservoir cosmetic composition
CN101632841B (zh) * 2009-08-21 2012-10-03 暨南大学 含海藻酸盐、糖胺聚糖和胶原的组织工程支架及其制备方法
US20120064136A1 (en) * 2010-09-10 2012-03-15 Nanobio Corporation Anti-aging and wrinkle treatment methods using nanoemulsion compositions

Also Published As

Publication number Publication date
RS58258B1 (sr) 2019-03-29
SI3024505T1 (sl) 2019-03-29
DK3024505T3 (en) 2019-02-18
AU2014293717A1 (en) 2016-02-18
RU2016105242A (ru) 2017-08-30
HRP20190132T1 (hr) 2019-03-22
TR201309048A2 (tr) 2015-02-23
PL3024505T3 (pl) 2019-07-31
US9517215B2 (en) 2016-12-13
CN105492033A (zh) 2016-04-13
CA2919422C (en) 2021-07-27
HUE041810T2 (hu) 2019-05-28
ES2707698T3 (es) 2019-04-04
CN105492033B (zh) 2019-01-18
US20160151302A1 (en) 2016-06-02
EP3024505B1 (en) 2018-10-24
RU2673665C2 (ru) 2018-11-29
BR112016001573B1 (pt) 2020-08-18
ZA201600594B (en) 2017-03-29
EP3024505A1 (en) 2016-06-01
AU2014293717B2 (en) 2017-06-15
PT3024505T (pt) 2019-02-01
CA2919422A1 (en) 2015-01-29
LT3024505T (lt) 2019-02-11
WO2015012775A1 (en) 2015-01-29
JP2016525410A (ja) 2016-08-25

Similar Documents

Publication Publication Date Title
US9814744B2 (en) Decellularized adipose cell growth scaffold
JP2023078307A (ja) 創傷治癒薬
CN113924132B (zh) 用于伤口护理的新型多糖基水凝胶支架
JP6530392B2 (ja) 相乗効果を有し組織修復を行う微粒子を備えた真皮基質とその製造方法
US20250134801A1 (en) Novel methods for decellularizing extracellular matrix
DE60007973T2 (de) Matrixprotein zusammensetzungen für pfropfung in nicht mineralisierten geweben
Huynh Hydrogel dressings: Revolutionizing burn care with innovative wound healing technology
RU2372922C1 (ru) Способ лечения глубокого ожога кожи
CN119868628A (zh) 一种用于止血和促成骨的基于鲵皮肤分泌物的海绵材料
KR20240158910A (ko) 세포외 기질(ecm)을 탈세포화하고 탈세포화된 ecm 젤을 제조하기 위한 개선된 방법 및 이의 용도
Liu et al. Engineering Biomimetic Aloe Vera Sponges with Steerable Photothermal Effects for Stage-Wise Acceleration of Wound Healing
Fernandes Development of Polymeric Matrices for the Application in Skin Regeneration

Legal Events

Date Code Title Description
A529 Written submission of copy of amendment under article 34 pct

Free format text: JAPANESE INTERMEDIATE CODE: A529

Effective date: 20160218

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20170130

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20170130

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20170614

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180327

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20180323

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20180627

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180629

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20181030

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190129

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20190129

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20190423

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20190516

R150 Certificate of patent or registration of utility model

Ref document number: 6530392

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees